 |
|
|
REFERENCES
1.
Dorsch JA, Dorsch SE: Controlling trace gas levels.
In Dorsch JA, Dorsch SE (eds): Understanding Anesthesia
Equipment: Construction, Care and Complications, 3rd ed. Baltimore Williams &
Wilkins, 1994, p 281.
2.
National Institute for Occupational Safety and Health:
Criteria for a Recommended Standard: Occupational Exposure to Waste Anesthetic
Gases and Vapors. DHEW (NIOSH) Publication No. 77-140, 1977.
3.
Flemming DC, Johnstone RE: Recognition thresholds
for diethyl ether and halothane. Anesthesiology 46:68, 1977.
4.
Hoerauf KH, Wallner T, Akca O, et al: Exposure
to sevoflurane and nitrous oxide during four different methods of anesthetic induction.
Anesth Analg 88:925–929, 1999.
5.
Kanmura Y, Sakai J, Yoshinaka H, Shirao K: Causes
of nitrous oxide contamination in operating rooms. Anesthesiology 90:693–696,
1999.
6.
Vaisman AL: Working conditions in the operating
room and their effect on the health of anesthetists [in Russian]. Eksp Khir Anesteziol
12:44, 1967.
7.
Spence AA, Cohen EN, Brown BW Jr, et al: Occupational
hazards for operating room-based physicians: Analysis of data from the United States
and the United Kingdom. JAMA 238:955, 1977.
8.
Buring JE, Hennekens CH, Mayrent SL, et al: Health
experiences of operating room personnel. Anesthesiology 62:325, 1985.
9.
Tannenbaum TN, Goldberg RJ: Exposure to anesthetic
gases and reproductive outcome: A review of the epidemiologic literature. J Occup
Med 27:659, 1985.
10.
Vessey MP: Epidemiological studies of the occupational
hazards of anaesthesia: A review. Anaesthesia 33:430, 1978.
11.
Spence AA, Knill-Jones RP: Is there a health hazard
in anaesthetic practice? Br J Anaesth 50:713, 1978.
12.
Waste Anesthetic Gases: Information for Management
in Anesthetizing Areas and the Postanesthetic Care Unit (PACU). Task Force on Trace
Anesthetic Gases, American Society of Anesthesiologists, 2004.
13.
Mazze RI, Lecky JH: The health of operating room
personnel. Anesthesiology 62:226, 1985.
14.
Bruce DL, Bach MJ: Effects of trace anaesthetic
gases on behavioral performance of volunteers. Br J Anaesth 48:871, 1976.
15.
Smith G, Shirley AW: A review of the effects of
trace concentrations of anaesthetics on performance. Br J Anaesth 50:701, 1978.
16.
Gambill AF, McCallum RN, Henrichs TF: Psychomotor
performance following exposure to trace concentrations of inhalation anesthetics.
Anesth Analg 58:475, 1979.
17.
Voelz GL: Ionizing radiation. In
Zenz C (ed): Occupational Medicine: Principles and Practical Applications, 2nd
ed. Chicago, Year Book, 1988, p 426.
18.
Bushong SC: Radiologic Science for Technologists:
Physics, Biology, and Protection, 4th ed. St Louis, CV Mosby, 1988.
19.
Barker D: Protection and safety in the x-ray department.
Radiography 44:45, 1978.
20.
Mohr H: The design of x-ray equipment for use
in operating rooms. Med Biol Eng 11:396, 1973.
21.
Kiviniitty K, Lahti R, Lahde S, et al: Radiation
doses from x-ray units used outside radiology departments. Health Phys 38:419, 1980.
22.
Holmes JA: A summary of safety considerations
for the medical and surgical practitioner. In Apfelberg
DB (ed): Evaluation and Installation of Laser Systems. New York, Springer-Verlag,
1987, p 69.
23.
Nezhat C, Winer WK, Nezhat F, et al: Smoke from
laser surgery: Is there a health hazard? Lasers Surg Med 7:376, 1987.
24.
Baggish MS, Baltoyannis P, Sze E: Protection of
the rat lung from the harmful effects of laser smoke. Lasers Surg Med 8:248, 1988.
25.
Byrne PO, Sisson PR, Oliver PD, et al: Carbon
dioxide laser irradiation of bacterial targets in vitro. J Hosp Infect 9:265, 1987.
26.
Garden JM, O'Banion K, Shelnitz LS, et al: Papillomavirus
in the vapor of carbon dioxide laser-treated verrucae. JAMA 259:1199, 1988.
27.
Ferenczy A, Bergeron C, Richart RM: Human papillomavirus
DNA in CO2
laser-generated plume of smoke and its consequences to the
surgeon. Obstet Gynecol 75:114, 1990.
28.
Baggish MS, Poiesz BJ, Joret D, et al: Presence
of human immunodeficiency virus DNA in laser smoke. Lasers Surg Med 11:197, 1991.
29.
Hallmo P, Naess O: Laryngeal papillomatosis with
human papillomavirus DNA contracted by a laser surgeon. Eur Arch Otorhinolaryngol
248:425, 1991.
30.
du Moulin GC, Hedley-Whyte J: Hospital-associated
viral infection and the anesthesiologist. Anesthesiology 59:51, 1983.
31.
Department of Labor, Occupational Health and Safety
Administration: Occupational exposure to bloodborne pathogens: Final rule (29 CFR
Part 1910.1030).
32.
Gerbert B, Maguire B, Badner V, et al: Why fear
persists: Health care professionals and AIDS. JAMA 260:3481, 1988.
33.
Berkelman RL, Heyward WL, Stehr-Green JK, et al:
Epidemiology of human immunodeficiency virus infection and acquired immunodeficiency
syndrome. Am J Med 86:761, 1989.
34.
Kessler HA, Bick JA, Pottage JC Jr, et al: AIDS.
Part I. Dis Mon 38:633, 1992.
35.
Gourevitch MN: The epidemiology of HIV and AIDS:
Current trends. Med Clin North Am 80:1223, 1996.
36.
Centers for Disease Control and Prevention: Impact
of the expanded AIDS surveillance case definition on AIDS case reporting—United
States, first quarter, 1993. MMWR Morb Mortal Wkly Rep 42:308, 1993.
37.
Rosenberg PS: Scope of the AIDS epidemic in the
United States. Science 270:1372, 1995.
38.
Update: Trends in AIDS incidence—United
States, 1996. MMWR Morb Mortal Wkly Rep 46:861, 1997.
39.
Update: Trends in AIDS incidence, deaths and prevalence—United
States, 1996. MMWR Morb Mortal Wkly Rep 46:165, 1997.
40.
"Technical Notes," HIV/AIDS Surveillance Report,
vol 12, no 1: Centers for Disease Control and Prevention, 2000. www.cdc.gov/hiv/stats/hasr1201/technote.htm.
41.
Weiss SH: Risks and issues for the health care
worker in the human immunodeficiency virus era. Med Clin North Am 81:555, 1997.
42.
Kelen GD, Fritz S, Qaqish B, et al: Unrecognized
human immunodeficiency virus infection in emergency department patients. N Engl
J Med 318:1645, 1988.
43.
Surveillance of Health Care Workers with HIV/AIDS:
Centers for Disease Control and Prevention, 2002. www.cdc.gov/hiv/pubs/facts/hcwsurv.htm.
44.
Tait AR, Tuttle DB: Prevention of occupational
transmission of human immunodeficiency virus and hepatitis B among anesthesiologists:
A survey of anesthesiology practice. Anesth Analg 79:623, 1994.
45.
Greene ES, Berry AJ, Arnold WP III, et al: Percutaneous
injuries in anesthesia personnel. Anesth Analg 83:273, 1996.
46.
Centers for Disease Control and Prevention: Patient
exposures to HIV during nuclear medicine procedures. MMWR Morb Mortal Wkly Rep 41:575,
1992.
47.
Lanphear BP: Trends and patterns in the transmission
of bloodborne pathogens to health care workers. Epidemiol Rev 16:437, 1994.
48.
Buergler JM, Kim R, Thisted RA, et al: Risk of
human immunodeficiency virus in surgeons, anesthesiologists, and medical students.
Anesth Analg 75:118, 1992.
49.
Centers for Disease Control and Prevention: Update:
Acquired immunodeficiency virus infection among healthcare workers. MMWR Morb Mortal
Wkly Rep 37:229, 1988.
50.
Centers for Disease Control and Prevention: Update:
Investigations of persons treated by HIV-infected health-care workers—United
States. MMWR Morb Mortal Wkly Rep 42:329, 1993.
51.
Centers for Disease Control and Prevention: Recommendations
for prevention of HIV transmission in health-care settings. MMWR Morb Mortal Wkly
Rep 36:1S, 1987.
52.
U.S. Public Health Service: Updated U.S. Public
Health Service guidelines for the management of occupational exposures to HBV, HCV,
and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep 50(RR-11):1–42,
2001. www.cdc.gov/mmwr/preview/mmwrhtml/rr5011a1.htm.
53.
Browne RA, Chernesky MA: Viral hepatitis and the
anesthetist. Can Anaesth Soc J 31:279, 1984.
54.
Berry AJ, Issacson IJ, Kane MA, et al: A multicenter
study of the epidemiology of hepatitis B in anesthesia residents. Anesth Analg 64:672,
1985.
55.
Centers for Disease Control and Prevention: Inactivated
hepatitis B virus vaccine. MMWR Morb Mortal Wkly Rep 31:317, 1982.
56.
Centers for Disease Control and Prevention: Changing
patterns of groups at high risk for hepatitis B in the United States. MMWR Morb
Mortal Wkly Rep 37:429, 1988.
57.
Gerberding JL: Drug therapy: Management of occupational
exposures to blood-borne viruses. N Engl J Med 332:444, 1995.
58.
Odaka N, Eldred L, Cohen S, et al: Comparative
immunogenicity of plasma and recombinant hepatitis B virus vaccines in homosexual
men. JAMA 260:3635, 1988.
59.
Gerberding JL: Risks to health care workers from
occupational exposure to hepatitis B virus, human immunodeficiency virus and cytomegalovirus.
Infect Dis Clin North Am 3:735, 1989.
60.
Alter MJ: Epidemiology of hepatitis C in the west.
Semin Liver Dis 15:5, 1995.
61.
Choo QL, Kuo G, Weiner AJ, et al: Isolation of
a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science
244:359, 1989.
62.
Kuo G, Choo QL, Alter HJ, et al: An assay for
circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.
Science 244:362, 1989.
63.
Cooper BW, Krusell A, Tilton RC, et al: Seroprevalence
of antibodies to hepatitis C virus in high-risk hospital personnel. Infect Control
Hosp Epidemiol 13:82, 1992.
64.
Hofmann H, Kunz C: Low risk of health care workers
for infection with hepatitis C virus. Infection 18:286, 1990.
65.
Wormser GP, Forseter G, Joline C, et al: Hepatitis
C infection in the health care setting. I. Low risk from parenteral exposure to
blood of human immunodeficiency virus-infected patients. Am J Infect Control 19:237,
1991.
66.
Mitsui T, Iwano K, Yamakazi C, et al: Hepatitis
C virus in medical personnel after needlestick accident. Hepatology 16, 1300, 1992.
67.
Centers for Disease Control and Prevention: Recommendations
for follow-up of health-care workers after occupational exposure to hepatitis C virus.
MMWR Morb Mortal Wkly Rep 46:603, 1966.
68.
Tait AR: Occupational transmission of tuberculosis:
Implications for anesthesiologists. Anesth Analg 85:444, 1997.
69.
Edlin BR, Tokars JI, Grieco MH, et al: An outbreak
of multidrug-resistant tuberculosis among hospitalized patients with the acquired
immunodeficiency syndrome. N Engl J Med 326:1514, 1992.
70.
Beck-Sague C, Dooley SW, Hutton M, et al: Hospital
outbreak of multidrug-resistant Mycobacterium tuberculosis
infections: Factors in transmission to staff and HIV-infected patients. JAMA 268:1280,
1992.
71.
Gordin F: Tuberculosis control: Back to the future?
JAMA 267:2649, 1992.
72.
Centers for Disease Control and Prevention: Guidelines
for preventing transmission of tuberculosis in health-care settings, with special
focus on HIV-related issues. MMWR Recomm Rep 39(RR-17):1, 1990.
73.
Centers for Disease Control and Prevention: Management
of persons exposed to multidrug-resistant tuberculosis. MMWR Recomm Rep 41(RR-11):61–71,
1992.
74.
Centers for Disease Control and Prevention: Tuberculosis
morbidity—United States, 1996. MMWR Morb Mortal Wkly Rep 46:695, 1997.
75.
Centers for Disease Control and Prevention: Guidelines
for preventing the transmission of Mycobacterium tuberculosis
in health-care facilities, 1994. MMWR Recomm Rep 43(RR-13):1–132, 1994.
76.
Llewelyn CA, Hewitt PE, Knight RSG, et al: Possible
transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363:417,
2004.
77.
Ironside JW, Head MW: Variant Creutzfeldt-Jakob
disease and its transmission by blood. J Thromb Haemost 1:1479–1486, 2003.
78.
Brown P: Can Creutzfeldt-Jakob disease be transmitted
by transfusion? Curr Opin Hematol 2:472–477, 1995.
79.
Blattler T: Transmission of prion disease. APMIS
110:71–78, 2002.
80.
Jackson GS, Collinge J: The molecular pathology
of CJD: Old and new variants. J Clin Pathol Mol Pathol 54:393–399, 2001.
81.
Cashman NR: A prion primer. CMAJ 157:1381–1385,
1997.
82.
Pedersen NS, Smith E: Prion diseases: Epidemiology
in man. APMIS 110:14–22, 2002.
83.
Will RG: Acquired prion disease: Iatrogenic CJD,
variant CJD, kuru. Br Med Bull 66:255–265, 2003.
84.
Sachse C, Groschup MH, Warzok R, Greinacher A:
Role of variant Creutzfeldt-Jakob disease for safety of treatment with blood components:
Screening of lymphatic tissue is a potential tool for risk assessment. Eur J Haematol
70:11–16, 2003.
85.
Hill AF, Zeidler M, Ironside J, Collinge J: Diagnosis
of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349:99–100,
1997.
86.
Hill AF, Butterworth RJ, Joiner S, et al: Investigation
of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy
samples. Lancet 353:183–189, 1999.
87.
Ramasamy I, Law M, Collins S, Brooke F: Organ
distribution of prion proteins in variant Creutzfeldt-Jakob disease. Lancet Infect
Dis 3:214–222, 2003.
88.
Hill AF, Collinge J: Subclinical prion infection
in humans and animals. Br Med Bull 66:161–170, 2003.
89.
Evatt BL: Prions and haemophilia: Assessment
of risk. Haemophilia 4:628–633, 1998.
90.
Bingham B: New variant CJD-BSE (mad cow disease).
The need for disposable ENT instruments. Int J Pediatr Otorhinolaryngol 62:203–206,
2002.
91.
Brown P, Will RG, Bradley R, et al: Bovine spongiform
encephalopathy and variant Creutzfeldt-Jakob disease: Background, evolution, and
current concerns. Emerg Infect Dis 7:6–16, 2001.
92.
Revised Preventative Measures to Reduce the Possible
Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob
Disease (vCJD) by Blood and Blood Products. Food and Drug Administration, 2002.
www.fda.gov/cber/gdlns/cjdvdjd.htm.
93.
Boulton F: The impact of variant CJD on transfusion
practices in the UK. Transfus Apheresis Sci 28:107–116, 2003.
94.
Centers for Disease Control and Prevention: Update:
Universal precautions for prevention of transmission of human immunodeficiency virus,
hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR
Morb Mortal Wkly Rep 37:377, 1988.
95.
Garner JS: Guideline for isolation precautions
in hospitals. Infect Control Hosp Epidemiol 17:54, 1996.
96.
Preventing Needlestick Injuries in Health Care
Settings. Centers for Disease Control and Prevention, 2000. www.cdc.gov/niosh/2000-108.html.
97.
Needlestick Safety and Prevention Act, 2000:114.
frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=1006_cong_bills&docid=f:h5178eh.txt.
98.
Needlestick Safety and Prevention Act Signed into
Law. Occupational Health Research, 2000. www.systoc.com/newscomments/news/november2000/111500ne.htm.
99.
Pyrek K: Study Shows Needlestick Injuries ...
On the Gradual Decline—1 of 2. Infection Control Today, 2003. www.infectioncontroltoday.com/articles/361feat1.html.
100.
Kam PC, Lee MS, Thompson JF: Latex allergy:
An emerging clinical and occupational health problem. Anaesthesia 52:570, 1997.
101.
Konrad C, Fieber T, Gerber H, et al: The prevalence
of latex sensitivity among anesthesiology staff. Anesth Analg 84:629, 1997.
102.
NIOSH Alert: Preventing Allergic Reactions to
Natural Rubber Latex in the Workplace. DHHS (NIOSH) Publication No. 97-135, 1997.
103.
Kryter KD: The Effects of Noise on Man, 2nd ed.
San Diego, CA, Academic Press, 1985.
104.
Shapiro RA, Berland T: Noise in the operating
room. N Engl J Med 287:1236, 1972.
105.
Falk SA, Woods NF: Hospital noise: Levels and
potential health hazards. N Engl J Med 289:774, 1973.
106.
Martin L: The Libby Zion case. Law vs. Medicine:
The Endless Debate. http://www.mtsinai.org/pulmonary/books/house/legal.html
107.
Horowitz C: The doctor is out. New York Magazine,
2003.
108.
Holzman IR, Barnett SH: The Bell Commission:
Ethical implications for the training of physicians. Mt Sinai J Med 67:136–139,
2000.
109.
Paice E, Rutter H, Wetherell M, et al: Stressful
incidents, stress and coping strategies in the pre-registration house officer year.
Med Educ 36:56–65, 2002.
110.
Firth-Cozens J: Emotional distress in junior
house officers. BMJ (Clin Res Ed) 295:533–536, 1987.
111.
Firth-Cozens J, Greenhalgh J: Doctors' perceptions
of the links between stress and lowered clinical care. Soc Sci Med 44:1017–1022,
1997.
112.
Gordon NP, Cleary PD, Parker CE, et al: The prevalence
and health impact of shiftwork. Am J Public Health 76:1225, 1986.
113.
Mitler MM, Carskadon MA, Czeisler CA, et al:
Catastrophes, sleep, and public policy: Consensus report. Sleep 11:100, 1988.
114.
Howard SK, Healzer JM, Gaba DM: Sleep and work
schedules of anesthesia residents: A national study [abstract]. Anesthesiology
87:A932, 1997.
115.
Denisco RA, Drummond JN, Gravenstein JS: The
effect of fatigue on the performance of a simulated anesthetic monitoring task.
J Clin Monit 3:22–24, 1987.
116.
Veasey S, Rosen R, Barzansky B, et al: Sleep
loss and fatigue in residency training: A reappraisal. JAMA 288:1116–1124,
2002.
117.
Weinger MB, Ancoli-Israel S: Sleep deprivation
and clinical performance. JAMA 287:955–957, 2002.
118.
Robbins J, Gottlieb F: Sleep deprivation and
cognitive testing in internal medicine house staff. West J Med 152:82–86,
1990.
119.
Cooper JB, Newbower RS, Kitz RJ: An analysis
of major errors and equipment failures in anesthesia management: Considerations
for prevention and detection. Anesthesiology 60:34, 1984.
120.
Howard SK, Gaba DM, Smith BE, et al: Simulation
study of rested versus sleep-deprived anesthesiologists. Anesthesiology 98:1345–1355,
discussion 5A, 2003.
121.
Grantcharov TP, Bardram L, Funch-Jensen P, Rosenberg
J: Laparoscopic performance after one night on call in a surgical department: Prospective
study. BMJ 323:1222–1223, 2001.
122.
Haynes DF, Schwedler M, Dyslin DC, et al: Are
postoperative complications related to resident sleep deprivation? South Med J 88:283–289,
1995.
123.
Marcus CL, Loughlin GM: Effect of sleep deprivation
on driving safety in housestaff. Sleep 19:763–766, 1996.
124.
Geer RT, Jobes DR, Tew JD Jr, et al: Incidence
of automobile accidents involving anesthesia residents after on-call duty cycles
[abstract]. Anesthesiology 87:A938, 1997.
125.
Engel W, Seime R, Powell V, D'Alessandri R: Clinical
performance of interns after being on call. South Med J 80:761–763, 1987.
126.
Ford CV, Wentz DK: The internship year: A study
of sleep, mood states, and psychophysiologic parameters. South Med J 77:1435–1442,
1984.
127.
Orton DI, Gruzelier JH: Adverse changes in mood
and cognitive performance of house officers after night duty. BMJ 298:21–23,
1989.
128.
Gottlieb DJ, Parenti CM, Peterson CA, Lofgren
RP: Effect of a change in house staff work schedule on resource utilization and
patient care. Arch Intern Med 151:2065–2070, 1991.
129.
Libby Zion Law. New York State Department of
Health Code. Section 405.4, 1998.
130.
Gaba DM, Howard SK: Patient safety: Fatigue
among clinicians and the safety of patients. N Engl J Med 347:1249–1255, 2002.
131.
Green MJ: What (if anything) is wrong with residency
overwork? Ann Intern Med 123:512–517, 1995.
132.
Trowbridge RW: Legislation, accreditation, and
market-driven and other approaches to improving patient safety. In
Making Health Care Safer, vol 2004. UCSF-Stanford University Evidence-Based Practice
Center.
133.
Buysse DJ, Barzansky B, Dinges D, et al: Sleep,
fatigue, and medical training: Setting an agenda for optimal learning and patient
care. Sleep 26:218–225, 2003.
134.
Dickson DE: Stress. Anaesthesia 51:523, 1966.
135.
Simpson LA, Grant L: Sources and magnitude of
job stress among physicians. J Behav Med 14:27, 1991.
136.
Kain ZN, Chan KM, Katz JD, et al: Anesthesiologists
and acute perioperative stress: A cohort study. Anesth Analg 95:177–183,
2002.
137.
Seeley HF: The practice of anesthesia: A stressor
for the middle-aged? Anaesthesia 51:571, 1996.
138.
Hilzenrath DS: Disability Claims Rise for Doctors;
Disappointed with HMOs, Many Opt out for Benefits. The Washington Post. Washington,
DC, Feb 16, 1998, p A.01.
139.
Musto DF: Cocaine's history, especially the American
experience. Ciba Found Symp 166:7–14, discussion 14–19, 1992.
140.
Brecher E: Some eminent narcotics addicts. In
The Consumer Union Report on Licit and Illicit Drugs. Consumer Reports Magazine,
1972.
141.
Zacny JP, Galinkin JL: Psychotropic drugs used
in anesthesia practice: Abuse liability and epidemiology of abuse. Anesthesiology
90:269–288, 1999.
142.
Rinaldi RC, Steindler EM, Wilford BB, et al:
Clarification and standardization of substance abuse terminology. JAMA 259:555,
1988.
143.
Leshner AI: Addiction is a brain disease, and
it matters. Science 278:45, 1997.
144.
Cloninger CR: Neurogenetic adaptive mechanisms
in alcoholism. Science 236:410, 1987.
145.
Ingraham LJ, Wender PH: Risk for affective disorder
and alcohol and other drug abuse in the relatives of affectively ill adoptees. J
Affect Disord 26:45, 1992.
146.
Cadoret R, Troughton E, O'Gorman TW, et al: An
adoption study of genetic and environmental factors in drug abuse. Arch Gen Psychiatry
43:1131, 1986.
147.
Thacker SB, Veech RL, Vernon AA, et al: Genetic
and biochemical factors relevant to alcoholism. Clin Exp Res 8:375, 1984.
148.
Myers RD: Multiple metabolite theory, alcohol
drinking and the alcogene. Prog Clin Biol Res 183:201, 1985.
149.
Koob GF, LeMoal M: Drug abuse: Hedonic, homeostatic
dysregulation. Science 278:52, 1997.
150.
Nestler EJ, Aghajanian GK: Molecular and cellular
basis of addiction. Science 278:58, 1997.
151.
O'Brien CP: A range of research-based pharmacotherapies
for addiction. Science 278:66, 1997.
152.
McAuliffe WE, Rohman M, Santangelo S, et al:
Psychoactive drug use among practicing physicians and medical students. N Engl J
Med 315:805–810, 1986.
153.
Hughes PH, Brandenburg N, Baldwin DC Jr, et al:
Prevalence of substance use among US physicians. JAMA 267:2333, 1992.
154.
Myers T, Weiss E: Substance use by internes and
residents: An analysis of personal, social and professional differences. Br J Addict
82:1091–1099, 1987.
155.
Hughes PH, Conard SE, Baldwin DC Jr, et al: Resident
physician substance use in the United States. JAMA 265:2069–2073, 1991.
156.
Hughes PH, Baldwin DC Jr, Sheehan DV, et al:
Resident physician substance use, by specialty. Am J Psychiatry 149:1348–1354,
1992.
157.
Baldwin DC Jr, Hughes PH, Conard SE, et al: Substance
use among senior medical students. A survey of 23 medical schools. JAMA 265:2074–2078,
1991.
158.
Vaillant GE: Physician, cherish thyself. The
hazards of self-prescribing. JAMA 267:2373–2374, 1992.
159.
Flaherty JA, Richman JA: Substance use and addiction
among medical students, residents, and physicians. Psychiatr Clin North Am 16:189–197,
1993.
160.
Ward CF, Ward GC, Saidman LJ: Drug abuse in anesthesia
training programs, a survey: 1970 through 1980. JAMA 250:922, 1983.
161.
Gravenstein JS, Kory WP, Marks RG: Drug abuse
by anesthesia personnel. Anesth Analg 62:467, 1983.
162.
Menk EJ, Baumgarten RK, Kingsley CP, et al: Success
of reentry into anesthesiology training programs of residents with a history of substance
abuse. JAMA 263:3060, 1990.
163.
Baird WL, Morgan M: Substance misuse amongst
anaesthetists. Anaesthesia 55:943–945, 2000.
164.
Arens JF: Substance abuse: One anesthesiologist's
perspective. Bull Am Coll Surg 78:10–14, 1993.
165.
Lutsky I, Hopwood M, Abram SE, et al: Use of
psychoactive substances in three medical specialities: Anaesthesia, medicine and
surgery. Can J Anaesth 41:561–567, 1994.
166.
Talbott GD, Gallegos KV, Wilson PO, et al: The
Medical Association of Georgia's Impaired Physicians Program: Review of the first
1000 physicians: Analysis of specialty. JAMA 257:2927, 1987.
167.
Gallegos KV, Browne CH, Veit FW, et al: Addiction
in anesthesiologists: Drug access and patterns of substance abuse. QRB Qual Rev
Bull 14:116–122, 1988.
168.
Herrington RE, Benzer DG, Jacobson GR, et al:
Treating substance-use disorders among physicians. JAMA 247:2253, 1982.
169.
Gualtieri AC, Cosentino JP, Becker JS: The California
experience with a diversion program for impaired physicians. JAMA 249:226, 1983.
170.
Ikeda R, Pelton C: Diversion programs for impaired
physicians. West J Med 152:617–621, 1990.
171.
Shore JH: The Oregon experience with impaired
physicians on probation: An eight-year follow-up. JAMA 257:2931, 1987.
172.
Hines R: Substance Abuse in Anesthesia Providers:
An Update, 2002. www.anesthesia.org.cn/asa2002/rcl_source/164_Hines.pdf.
173.
Model Curriculum on Drug Abuse and Addiction for
Residents in Anesthesiology. American Society of Anesthesiology. http://www.asahq.org/ProInfo/curriculum.htm
174.
McCall TB: The impact of long working hours on
resident physicians. N Engl J Med 318:775, 1988.
175.
Soto RG, Rosen GP: Pediatric death: Guidelines
for the grieving anesthesiologist. J Clin Anesth 15:275–277, 2003.
176.
Klein RL, Stevens WC, Kingston HG: Controlled
substance dispensing and accountability in United States anesthesiology residency
programs. Anesthesiology 77:806–811, 1992.
177.
Booth JV, Grossman D, Moore J, et al: Substance
abuse among physicians: A survey of academic anesthesiology programs. Anesth Analg
95:1024–1030, 2002.
178.
McAuliffe WE, Rohman M, Santangello S, et al:
Psychoactive drug use among practicing physicians and medical students. N Engl
J Med 315:805, 1986.
179.
Ullmann D, Phillips RL, Beeson WL, et al: Cause-specific
mortality among physicians with differing life-styles. JAMA 265:2352–2359,
1991.
180.
Carpenter LM, Swerdlow AJ, Fear NT: Mortality
of doctors in different specialties: Findings from a cohort of 20000 NHS hospital
consultants. Occup Environ Med 54:388–395, 1997.
181.
Linde HW, Mesnick PS, Smith NJ: Causes of death
among anesthesiologists: 1930–1946. Anesth Analg 60:1–7, 1981.
182.
Lew EA: Mortality experience among anesthesiologists,
1954–1976. Anesthesiology 51:195–199, 1979.
183.
Alexander BH, Checkoway H, Nagahama SI, Domino
KB: Cause-specific mortality risks of anesthesiologists. Anesthesiology 93:922–930,
2000.
184.
Bruce DL, Eide A, Smith NJ, et al: A prospective
survey of anesthesiologist mortality, 1967–1971. Anesthesiology 41:71, 1974.
185.
Lecky JH, Aukberg SJ, Conahan T III, et al: A
departmental policy addressing chemical substance abuse. Anesthesiology 65:414,
1986.
186.
Spiegelman WG, Saunders L, Mazze RI: Addiction
and anesthesiology. Anesthesiology 60:335, 1984.
187.
Talbott GD: Elements of the impaired physicians
program. J Med Assoc Ga 73:749, 1984.
188.
Johnson VE: Intervention: How to Help Someone
Who Doesn't Want Help. Minneapolis, MN, Johnson Institute Books, 1986.
189.
Talbott GD, Martin CA: Relapse and recovery:
Special issues for chemically dependent physicians. J Med Assoc Ga 73:763, 1984.
190.
Moncrieff J, Drummond DC: New drug treatments
for alcohol problems: A critical appraisal. Addiction 92:939, 1997.
191.
Equal Employment Opportunity Commission: A Technical
Assistance Manual on the Employment Provisions (Title 1) of the Americans with Disabilities
Act. Washington, DC, U.S. Government Printing Office, 1992.
192.
Morse RM, Martin MA, Swenson WM, et al: Prognosis
of physicians treated for alcoholism and drug dependence. JAMA 251:743, 1984.
193.
Booklet of Information. Hartford, CT, American
Board of Anesthesiology, 1993.
